VRC 701 - Influenza

Plasmid DNA vaccine + Seasonal TIV

Enrollment closed; in follow-up

The study examines the safety, tolerability & immunogenicity of a prime-boost vaccination regimen with an investigational plasmid DNA vaccine or placebo followed by the seasonal TIV vaccine.

  • Looking for healthy men and women, age 18 through 70
  • Recruiter: No longer recruiting participants

DMID 11-0034 

Enrollment closed; in follow-up

  • Participants 55-64years old  who have received exactly one PPV23 vaccine between 3 and 7 years ago